Purchase Order 36C25226P0149

The Department of Veterans Affairs Veterans Integrated Service Network 12 awarded a $1.34 million firm fixed-price purchase order to Exelan Pharmaceuticals Inc. for the supply and dispensing of Lenalidomide medication to support oncology and hematologic malignancy treatment protocols at Tomah VA Medical Center. The contract, awarded on January 16, 2026, with an ultimate completion date of January 15, 2027, requires Exelan to dispense Lenalidomide capsules in multiple dosages (2.5mg, 5mg, 10mg, 15mg, and 25mg) in compliance with the Lenalidomide Risk Evaluation and Mitigation Strategy program. Key service requirements include managing the complex prescription dispensing process with healthcare provider verification, patient counseling, next-day delivery with signature confirmation, and capped shipping fees of $250. The contract was awarded without set-aside designation on a fully open, competitive basis using Lowest Price Technically Acceptable evaluation criteria.

Exelan Pharmaceuticals, headquartered in Boca Raton, Florida, is an established federal pharmaceutical supplier with extensive experience serving the VA healthcare system and other federal agencies including the Department of Defense, Bureau of Prisons, and Indian Health Service. The company maintains a substantial portfolio of Indefinite Delivery Contracts and Blanket Purchase Agreements with the VA National Acquisition Center and Defense Logistics Agency, with cumulative ceiling values exceeding $400 million across multiple pharmaceutical products. Exelan performs substantially all work at its Boca Raton facility and has developed particular expertise in Lenalidomide supply, having previously fulfilled delivery orders for this medication across multiple Veterans Integrated Service Networks with values ranging from approximately $6,500 to $4.77 million.